Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Keratosis, Actinic 5Skin Neoplasms 3Radiodermatitis 3Breast Neoplasms 3Carcinoma, Squamous Cell 2Sarcoma, Alveolar Soft Part 1Head and Neck Neoplasms 1Dermatitis 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Low-Level Light Therapy 8Standard of Care 5Petrolatum 3Norepinephrine 3triethanolamine 2sapropterin 2Sodium Chloride 2Radiotherapy 2Curcumin 2Biafine 2eucerin 1epigallocatechin gallate 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1calcipotriene 1Zinc Oxide 1Triamcinolone Acetonide 1Thioctic Acid 1Sodium Hypochlorite 1Silver Sulfadiazine 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Dimethyl Sulfoxide 1Centella asiatica extract 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Radiodermatitis × Petrolatum × Clear all
NCT05553392 2024-09-04

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

Stratpharma AG

Phase NA Terminated
13 enrolled

Radiodermatitis

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

NCT02534129 2017-10-06

Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis

ProTechSure Scientific, Inc.

Phase 1/2 Terminated
13 enrolled 3 charts
Breast

Breast Neoplasms, Dermatitis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡